Mechanisms of Disease 2 HC31: Targeted therapy and hematological malignancies

HC31: Targeted therapy and hematological malignancies

Monoclonal antibodies

Tumor specific monoclonal antibodies:

CD20 is an IgG isotype expressed antigen on normal and malignant B-cells. It is used for treatment of many B-cell lymphomas → by targeting CD20 antigens, both malignant and normal B-cells are depleted.

Rituximab:

Chemotherapy combined with CHOP monoclonal antibodies leads to a significant increase of survival rates. Rituximab, a monoclonal antibody against CD20, leads to:

  • Complement system activation
    • A MAC is formed
  • NK-cell recruitment
    • Receptors bind to the humanized tail of rituximab
  • Apoptosis
    • Macrophages are attracted

Mechanisms of action:

Monoclonal antibodies can have different mechanisms of action:

  • Complement dependent cytotoxicity (CDC)
    1. The complement system is activated
    2. Hollow pipes are made in the cell surface
    3. Water enters the cell
    4. The cell explodes
  • Antibody dependent cellular cytotoxicity (ADCC)
    1. A B-lymphocyte plasma cell secretes antibodies which bind to an antigen on the pathogen
    2. The pathogen is phagocytosed by macrophages, destroyed by NK-cells or lysed via the complement system
  • Radio immunotherapy
    1. A radioactive particle such as yttrium is coupled to an IgG monoclonal antibody such as CD20 → can get close to the tumor cells
      • A form of local treatment
    2. Yttrium gives a small dose of β- or γ-radiation
    3. The tumor is directly targeted
  • Antibody drug conjugate
    1. A drug is bound to a monoclonal antibody such as CD30 → an ADC-CD30 complex is created
      • CD30 is expressed in Hodgkin lymphomas and anaplastic large cell lymphomas
    2. The ADC-CD30 complex travels to the lysosome
    3. MMAE is released in the cell → disrupts the microtubule network
      • Physical cell division is prevented by binding on a microtubule during cell division
    4. The G2-/M-phase is arrested → the cell cycle stops → apoptosis

Bispecific antibodies

Bispecific antibodies are a combination of 2 different antibodies to target B-cells with CD8 T-cells. A bispecific T-cell engager (BiTE) causes proliferation of T-cells via the following mechanism:

  1. 2 antibodies are coupled to create a bispecific monoclonal antibody with binatunumab → an antibody against CD3 antibody is coupled with an antibody against CD19
    • Anti-CD3 antibodies target T-cells
    • Anti-CD19 antibodies target B-cells
  2. The T-cell becomes activated and starts its immune function → cytokines are made
    • A T-cell can kill more cells than 1 B-cell
  3. The T-cell attacks malignant B-cells → perforins enter the B-cells and kill them

CAR T-cells

A T-cell has a T-cell receptor, which can recognize a peptide presented in an HLA molecule. To activate a T-cell receptor, additional costimulatory signals such as CD28 are necessary as well. If a T-cell receptor is activated, the T-cell proliferates and kills the target cell. A Chimeric antigen receptor (CAR) T-cell uses the intracellular part of a TCR and the extracellular part of a monoclonal antibody:

  1. T-cells are extracted through a leukapheresis procedure
  2. T-cells are expanded if necessary
    • Usually there already are enough T-cells
  3. CARs are reprogrammed into the T-cell
    • Using a viral vector, T-cells with a new gene part are transfused with costimulatory signals and the extracellular part is transfused with part of a monoclonal antibody
      • The CD3 zeta-chain of the TCR is used
      • An anti-CD19 antibody is used as monoclonal antibody
  4. Re-infusion of the CAR T-cells
    • Chemotherapy is used for lymphocyte depletion to make the CAR T-cells more effective
  5. The target cell is killed

(Dis)advantages:

CAR T-cells have several risks, but also benefits:

  • Risks
    • Normal B-cells are also destroyed
    • T-cells are activated and cytokines are excreted → cytokine release syndrome can occur
      • For this reason, CAR T-cells are only used in hospitals with good IC-departments
  • Benefits
    • Upon activation, CAR T-cells go into a memory state → a reaction is induced in case of tumor relapse
      • However, CAR T-cell survival is not as good as normal T-cell survival

Side effects

Side effects of monoclonal antibodies, BiTEs and CAR T-cells are:

  • Allergic reactions at the beginning of the infusion
    • Caused by monoclonal antibodies
  • Cytokine release syndrome
    • Symptoms
      • Hypotension
      • Fever
      • Tachycardia
      • Dyspnea
    • Released cytokines
      • TNF-α
      • IFN-γ
      • Interleukin-6
      • Interleukin-2
    • Caused by blina and CAR T-cells
      • People have died due to treatment with CAR T-cells
  • Tumor lysis syndrome
    • Lysis causes renal failure due to formation and release of uric acid crystals
      • Prevention with rasburicase or allopurinol → no release of uric acids
    • LDH release
  • Polyneuropathy
    • Monomethyl auristatin E (MMAE) conjugates to anti-CD30

Small molecules

Small molecules are also a form of targeted therapy. Small molecules can be used to treat chronic myeloid leukemia, where due to a translocation of chromosome 9 and 22 a fusion protein is made. This causes constitutive activation and increased proliferation. Targeted therapy consists of a drug that can take up the place of an ATP molecule, inhibiting phosphorylation of substrates → the effector mechanism doesn’t take place anymore. Imatinib is an example of target therapy.

In short, there are many signal transduction pathways, and many drugs which can inhibit particular molecules. In some tumors, the B-cell receptor is continuously active, which can be stopped by a small molecule.

Midostaurin:

Midostaurin is a new drug. It is an inhibitor of mutated Flt3, a surface cytokine receptor which is present on malignant acute myeloid leukemia cells. Inhibition of Flt3 results in increased cell death. Sometimes, midostaurin is used as maintenance treatment.

Image

Access: 
Public

Image

Join WorldSupporter!
This content is used in:

Mechanisms of Disease 2 2020/2021 UL

Search a summary

Image

 

 

Contributions: posts

Help other WorldSupporters with additions, improvements and tips

Add new contribution

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Image

Spotlight: topics

Check the related and most recent topics and summaries:
Institutions, jobs and organizations:
Activities abroad, study fields and working areas:
This content is also used in .....

Image

Check how to use summaries on WorldSupporter.org

Online access to all summaries, study notes en practice exams

How and why use WorldSupporter.org for your summaries and study assistance?

  • For free use of many of the summaries and study aids provided or collected by your fellow students.
  • For free use of many of the lecture and study group notes, exam questions and practice questions.
  • For use of all exclusive summaries and study assistance for those who are member with JoHo WorldSupporter with online access
  • For compiling your own materials and contributions with relevant study help
  • For sharing and finding relevant and interesting summaries, documents, notes, blogs, tips, videos, discussions, activities, recipes, side jobs and more.

Using and finding summaries, notes and practice exams on JoHo WorldSupporter

There are several ways to navigate the large amount of summaries, study notes en practice exams on JoHo WorldSupporter.

  1. Use the summaries home pages for your study or field of study
  2. Use the check and search pages for summaries and study aids by field of study, subject or faculty
  3. Use and follow your (study) organization
    • by using your own student organization as a starting point, and continuing to follow it, easily discover which study materials are relevant to you
    • this option is only available through partner organizations
  4. Check or follow authors or other WorldSupporters
  5. Use the menu above each page to go to the main theme pages for summaries
    • Theme pages can be found for international studies as well as Dutch studies

Do you want to share your summaries with JoHo WorldSupporter and its visitors?

Quicklinks to fields of study for summaries and study assistance

Main summaries home pages:

Main study fields:

Main study fields NL:

Follow the author: nathalievlangen
Work for WorldSupporter

Image

JoHo can really use your help!  Check out the various student jobs here that match your studies, improve your competencies, strengthen your CV and contribute to a more tolerant world

Working for JoHo as a student in Leyden

Parttime werken voor JoHo

Statistics
1495